Correlation Between Neuropace and Vycor Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and Vycor Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Vycor Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Vycor Medical, you can compare the effects of market volatilities on Neuropace and Vycor Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Vycor Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Vycor Medical.

Diversification Opportunities for Neuropace and Vycor Medical

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between Neuropace and Vycor is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Vycor Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vycor Medical and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Vycor Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vycor Medical has no effect on the direction of Neuropace i.e., Neuropace and Vycor Medical go up and down completely randomly.

Pair Corralation between Neuropace and Vycor Medical

Given the investment horizon of 90 days Neuropace is expected to generate 0.45 times more return on investment than Vycor Medical. However, Neuropace is 2.2 times less risky than Vycor Medical. It trades about 0.15 of its potential returns per unit of risk. Vycor Medical is currently generating about 0.05 per unit of risk. If you would invest  697.00  in Neuropace on September 30, 2024 and sell it today you would earn a total of  370.00  from holding Neuropace or generate 53.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Neuropace  vs.  Vycor Medical

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
Vycor Medical 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Vycor Medical are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady fundamental indicators, Vycor Medical displayed solid returns over the last few months and may actually be approaching a breakup point.

Neuropace and Vycor Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and Vycor Medical

The main advantage of trading using opposite Neuropace and Vycor Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Vycor Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vycor Medical will offset losses from the drop in Vycor Medical's long position.
The idea behind Neuropace and Vycor Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data